BioAdvance News

First-In-Class Novel Anti-Cancer Agent In Development By Niiki Pharma Shows Promising Phase I Results

By WebmasterJune 1, 2011November 1st, 2024No Comments

First-In-Class Novel Anti-Cancer Agent In Development By Niiki Pharma Shows Promising Phase I Results
Read more here

Previous PostYaupon Therapeutics, Inc. Appoints New Management Team
Next PostInfrascanner™ Software Designer Wins the Design of Medical Devices Top Award